Clinical Trial Update: A Single-Arm Investigator-Initiated Tria (IIT) Evaluating the Safety and Preliminary Efficacy of Autologous Drug-Loaded Neutrophils (NeuMed) in Patients With Unresectable Pancreatic Cancer [EARLY_Phase 1]

View source ↗

Summary

This document reports on a single-arm investigator-initiated Phase 1 trial evaluating autologous drug-loaded neutrophils (NeuMed) in patients with unresectable …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• NeuMed (Autologous drug-loaded neutrophils)

Snippet

Sponsor: The First Affiliated Hospital of Air Force Medicial University | Conditions: Unresectable Pancreatic Cancer | EARLY_Phase 1 | Status: RECRUITING